Pan-immune-inflammation and its dynamics: predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy

OBJECTIVES: Pan-immune-inflammation value (PIV) is defined by the neutrophil, platelet, monocyte, and lymphocyte counts and is associated with immune-checkpoint inhibitor (ICI) therapy outcomes in advanced non-small cell lung cancer (aNSCLC). However, PIV is dynamic under therapy and its longitudina...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yiqun, Gong, Lingyan, Gu, Pengyang, Hua, Yiwen, Sun, Yingfang, Ni, Songshi, Zhou, Xiaoyu, Tang, Zhiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557237/
https://www.ncbi.nlm.nih.gov/pubmed/37803437
http://dx.doi.org/10.1186/s12885-023-11366-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557237/
https://www.ncbi.nlm.nih.gov/pubmed/37803437
http://dx.doi.org/10.1186/s12885-023-11366-4

Ejemplares similares